UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Association between asthma and IgG levels specific for rhinovirus and respiratory syncytial virus antigens in children and adults

The journal of allergy and clinical immunology. Global, 2025-02, Vol.4 (1), p.100342, Article 100342

2025

Volltextzugriff (PDF)

Immunogenicity and safety of Ad26.RSV.preF/RSV preF protein vaccine at predicted intermediate- and end-of-shelf-life as an evaluation of potency throughout shelf life

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2344970-2344970

2024

Volltextzugriff (PDF)

Neutralizing activity of anti-respiratory syncytial virus monoclonal antibody produced in Nicotiana benthamiana

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2327142-2327142

2024

Volltextzugriff (PDF)

Economic burden of respiratory syncytial virus disease in Latin America: A systematic review

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2381298

2024

Volltextzugriff (PDF)

Implementation of the first respiratory syncytial (RSV) immunization campaign with nirsevimab in an autonomous community in Spain

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2365804

2024

Volltextzugriff (PDF)

Adjuvant system AS01: from mode of action to effective vaccines

Expert review of vaccines, 2024-12, Vol.23 (1), p.715-729

2024

Volltextzugriff (PDF)

Perceptions about respiratory syncytial virus (RSV) and attitudes toward the RSV vaccine among the general public in China: A cross-sectional survey

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2310916-2310916

2024

Volltextzugriff (PDF)

A latent class analysis of factors influencing preferences for infant respiratory syncytial virus (RSV) preventives among pregnant people in the United States

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2358566-2358566

2024

Volltextzugriff (PDF)

Respiratory syncytial virus: challenges in diagnosis and impact on the elderly: Recommendations from a multidisciplinary panel

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2388943

2024

Volltextzugriff (PDF)

Respiratory syncytial virus knowledge, attitudes, and perceptions among adults in the United States

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2303796

2024

Volltextzugriff (PDF)

Parental knowledge on the respiratory syncytial virus before the nirsevimab immunization program: Attitudes toward immunization in an autonomous community of Spain

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2357439

2024

Volltextzugriff (PDF)

Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2336357-2336357

2024

Volltextzugriff (PDF)

Exploring parental perspectives: Maternal RSV vaccination versus infant RSV monoclonal antibody

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2341505

2024

Volltextzugriff (PDF)

Respiratory syncytial virus immunization patterns in Germany, 2015-2020

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2380110

2024

Volltextzugriff (PDF)

Immunogenicity, safety and reactogenicity of Ad26.RSV.preF/RSV preF protein vaccine in adults aged 60 to 75 years: A comparison of phase 2b and phase 3 clinical trial material

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2383504

2024

Volltextzugriff (PDF)

Economic burden of cardiorespiratory hospitalizations associated with respiratory syncytial virus among United States adults in 2017-2019

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2364493

2024

Volltextzugriff (PDF)

A multivalent RSV vaccine based on the modified vaccinia Ankara vector shows moderate protection against disease caused by RSV in older adults in a phase 3 clinical study

Vaccine, 2024-12, Vol.42 (26), p.126427, Article 126427

2024

Volltextzugriff (PDF)

Modelling the epidemiological impact of maternal respiratory syncytial virus (RSV) vaccination in Australia

Vaccine, 2024-12, Vol.42 (26), p.126418, Article 126418

2024

Volltextzugriff (PDF)

Immunogenicity and safety of different dose levels of Ad26.RSV.preF/RSV preF protein vaccine in adults aged 60 years and older: A randomized, double-blind, placebo-controlled, phase 2a study

Vaccine, 2024-12, Vol.42 (26), p.126273, Article 126273

2024

Volltextzugriff (PDF)

Vaccines for Respiratory Syncytial Virus Prevention in Older Adults

The Annals of pharmacotherapy, 2024-12, Vol.58 (12), p.1218-1228

2024

Volltextzugriff (PDF)

Antibody levels against respiratory syncytial virus fusion protein conformations and lack of association with life-threatening infection in previously healthy infants

Vaccine, 2024-11, Vol.42 (25), p.126119, Article 126119

2024

Volltextzugriff (PDF)

Alexandria Real Estate Equities, Inc. Enables the Discovery, Development and Delivery of New Innovative Medicines That Are Key to Addressing Significant Unmet Medical Need

PR Newswire, 2024

2024

Volltextzugriff (PDF)

Vaccinations in pulmonary diseases - part 2: herpes zoste, RSV, pneumococcal infection and pertussis

Deutsche medizinische Wochenschrift (1946), 2024-11, Vol.149 (22), p.1372

2024

Volltextzugriff (PDF)

Enhanced susceptibility of pediatric airway epithelium to respiratory syncytial virus infection

The Journal of clinical investigation, 2024-11, Vol.134 (21)

2024

Volltextzugriff (PDF)

1 – 25 von 7.248

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.758)
Mit Volltextzugriff
(5.502)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(6.307)
Life Sciences & Biomedicine
(5.982)
Humans
(5.024)
Respiratory Syncytial Virus
(4.503)
Immunology
(3.803)
Animals
(2.691)
Female
(2.391)
Infectious Diseases
(2.216)
Infant
(2.127)
Respiratory Syncytial Viruses - Immunology
(2.084)
Respiratory Syncytial Virus Infections - Immunology
(1.944)
Biological And Medical Sciences
(1.886)
Microbiology
(1.787)
Male
(1.688)
Virology
(1.566)
Viruses
(1.555)
Infections
(1.379)
Mice
(1.341)
Child, Preschool
(1.249)
Medical Sciences
(1.246)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(6.514)
EZB Electronic Journals Library
(4.506)
IngentaConnect Journals
(3.183)
Journals@Ovid Complete
(3.008)
Publisher or Other Site
(2.299)
IngentaConnect Journals
(1.624)
Elsevier ScienceDirect Journals Complete
(1.441)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.273)
Oxford Journals Online Current
(867)
Wiley Online Library Journals
(800)
Jstor Complete Legacy
(781)
Oxford Journals 2020 Medicine
(771)
Wiley Online Library Full Collection 2018
(606)
Nature
(247)
Taylor & Francis Journals
(239)
Taylor & Francis
(223)
Taylor & Francis Online
(190)
Nexis Uni
(188)
Springer Nature - Complete Springer Journals
(154)
BMJ Journals
(105)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(16)
... seit 90 Tagen
(64)

Menü

Weitere Dienste

Einstellungen

Association between asthma and IgG levels specific for rhinovirus and respiratory syncytial virus antigens in children and adults

Immunogenicity and safety of Ad26.RSV.preF/RSV preF protein vaccine at predicted intermediate- and end-of-shelf-life as an evaluation of potency throughout shelf life

Neutralizing activity of anti-respiratory syncytial virus monoclonal antibody produced in Nicotiana benthamiana

Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol

Economic burden of respiratory syncytial virus disease in Latin America: A systematic review

Implementation of the first respiratory syncytial (RSV) immunization campaign with nirsevimab in an autonomous community in Spain

Adjuvant system AS01: from mode of action to effective vaccines

Perceptions about respiratory syncytial virus (RSV) and attitudes toward the RSV vaccine among the general public in China: A cross-sectional survey

A latent class analysis of factors influencing preferences for infant respiratory syncytial virus (RSV) preventives among pregnant people in the United States

Respiratory syncytial virus: challenges in diagnosis and impact on the elderly: Recommendations from a multidisciplinary panel

Respiratory syncytial virus knowledge, attitudes, and perceptions among adults in the United States

Parental knowledge on the respiratory syncytial virus before the nirsevimab immunization program: Attitudes toward immunization in an autonomous community of Spain

Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines

Exploring parental perspectives: Maternal RSV vaccination versus infant RSV monoclonal antibody

Respiratory syncytial virus immunization patterns in Germany, 2015-2020

Immunogenicity, safety and reactogenicity of Ad26.RSV.preF/RSV preF protein vaccine in adults aged 60 to 75 years: A comparison of phase 2b and phase 3 clinical trial material

Economic burden of cardiorespiratory hospitalizations associated with respiratory syncytial virus among United States adults in 2017-2019

A multivalent RSV vaccine based on the modified vaccinia Ankara vector shows moderate protection against disease caused by RSV in older adults in a phase 3 clinical study

Modelling the epidemiological impact of maternal respiratory syncytial virus (RSV) vaccination in Australia

Immunogenicity and safety of different dose levels of Ad26.RSV.preF/RSV preF protein vaccine in adults aged 60 years and older: A randomized, double-blind, placebo-controlled, phase 2a study

Vaccines for Respiratory Syncytial Virus Prevention in Older Adults

Antibody levels against respiratory syncytial virus fusion protein conformations and lack of association with life-threatening infection in previously healthy infants

Alexandria Real Estate Equities, Inc. Enables the Discovery, Development and Delivery of New Innovative Medicines That Are Key to Addressing Significant Unmet Medical Need

Vaccinations in pulmonary diseases - part 2: herpes zoste, RSV, pneumococcal infection and pertussis

Enhanced susceptibility of pediatric airway epithelium to respiratory syncytial virus infection

Aktive Filter

Suchergebnisse filtern